- Home
- QNCX vs LSBK Comparison
QNCX vs LSBK Comparison
Compare QNCX & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LSBK
- Stock Information
- Founded
- QNCX 2012
- LSBK 1891
- Country
- QNCX United States
- LSBK United States
- Employees
- QNCX N/A
- LSBK N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LSBK Savings Institutions
- Sector
- QNCX Health Care
- LSBK Finance
- Exchange
- QNCX Nasdaq
- LSBK Nasdaq
- Market Cap
- QNCX 47.7M
- LSBK 90.0M
- IPO Year
- QNCX 2019
- LSBK 2006
- Fundamental
- Price
- QNCX $1.78
- LSBK $15.97
- Analyst Decision
- QNCX Strong Buy
- LSBK
- Analyst Count
- QNCX 5
- LSBK 0
- Target Price
- QNCX $8.00
- LSBK N/A
- AVG Volume (30 Days)
- QNCX 320.7K
- LSBK 6.2K
- Earning Date
- QNCX 08-12-2025
- LSBK 07-23-2025
- Dividend Yield
- QNCX N/A
- LSBK 3.40%
- EPS Growth
- QNCX N/A
- LSBK 27.62
- EPS
- QNCX N/A
- LSBK 0.89
- Revenue
- QNCX N/A
- LSBK $25,795,000.00
- Revenue This Year
- QNCX N/A
- LSBK N/A
- Revenue Next Year
- QNCX N/A
- LSBK N/A
- P/E Ratio
- QNCX N/A
- LSBK $17.81
- Revenue Growth
- QNCX N/A
- LSBK N/A
- 52 Week Low
- QNCX $0.51
- LSBK $12.01
- 52 Week High
- QNCX $2.45
- LSBK $16.95
- Technical
- Relative Strength Index (RSI)
- QNCX 68.77
- LSBK 56.73
- Support Level
- QNCX $1.55
- LSBK $15.22
- Resistance Level
- QNCX $2.05
- LSBK $16.20
- Average True Range (ATR)
- QNCX 0.17
- LSBK 0.16
- MACD
- QNCX 0.02
- LSBK -0.01
- Stochastic Oscillator
- QNCX 64.00
- LSBK 76.53
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.